Financial Metrics

WTW WILLIS TOWERS WATSON PLC

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1.75	—	USD/shares	10-Q	2017-05-09
Quarterly	2016-06-30	0.51	-70.9%	USD/shares	10-Q	2017-08-07
Quarterly	2016-09-30	-0.23	-145.1%	USD/shares	10-Q	2017-11-06
Quarterly	2017-03-31	2.5	+1187.0%	USD/shares	10-Q	2018-05-08
Quarterly	2017-06-30	0.24	-90.4%	USD/shares	10-Q	2018-08-06
Quarterly	2017-09-30	-0.4	-266.7%	USD/shares	10-Q	2018-11-02
Quarterly	2018-03-31	1.61	+502.5%	USD/shares	10-Q	2019-05-03
Quarterly	2018-06-30	0.44	-72.7%	USD/shares	10-Q	2019-08-01
Quarterly	2018-09-30	0.33	-25.0%	USD/shares	10-Q	2019-11-01
Quarterly	2019-03-31	2.2	+566.7%	USD/shares	10-Q	2020-04-30
Quarterly	2019-06-30	1.06	-51.8%	USD/shares	10-Q	2020-07-30
Quarterly	2019-09-30	0.58	-45.3%	USD/shares	10-Q	2020-10-29
Quarterly	2020-03-31	2.34	+303.4%	USD/shares	10-Q	2021-04-29
Quarterly	2020-06-30	0.72	-69.2%	USD/shares	10-Q	2021-08-04
Quarterly	2020-09-30	0.93	+29.2%	USD/shares	10-Q	2021-10-28
Quarterly	2021-03-31	5.63	+505.4%	USD/shares	10-Q	2022-04-28
Quarterly	2021-06-30	1.41	-75.0%	USD/shares	10-Q	2022-07-28
Quarterly	2021-09-30	6.99	+395.7%	USD/shares	10-Q	2022-10-27
Quarterly	2022-03-31	1.03	-85.3%	USD/shares	10-Q	2023-04-27
Quarterly	2022-06-30	0.97	-5.8%	USD/shares	10-Q	2023-07-27
Quarterly	2022-09-30	1.72	+77.3%	USD/shares	10-Q	2023-10-26
Quarterly	2023-03-31	1.88	+9.3%	USD/shares	10-Q	2024-04-25
Quarterly	2023-06-30	0.88	-53.2%	USD/shares	10-Q	2024-07-25
Quarterly	2023-09-30	1.29	+46.6%	USD/shares	10-Q	2024-10-31
Quarterly	2024-03-31	1.83	+41.9%	USD/shares	10-Q	2025-04-24
Quarterly	2024-06-30	1.36	-25.7%	USD/shares	10-Q	2025-08-01
Quarterly	2024-09-30	-16.44	-1308.8%	USD/shares	10-Q	2025-10-30
Quarterly	2025-03-31	2.33	+114.2%	USD/shares	10-Q	2025-04-24
Quarterly	2025-06-30	3.32	+42.5%	USD/shares	10-Q	2025-08-01
Quarterly	2025-09-30	3.11	-6.3%	USD/shares	10-Q	2025-10-30
Annual	2016-12-31	3.04	—	USD/shares	10-K	2019-02-27
Annual	2017-12-31	4.18	+37.5%	USD/shares	10-K	2020-02-26
Annual	2018-12-31	5.27	+26.1%	USD/shares	10-K	2021-02-23
Annual	2019-12-31	8.02	+52.2%	USD/shares	10-K	2022-02-24
Annual	2020-12-31	7.65	-4.6%	USD/shares	10-K	2023-02-24
Annual	2021-12-31	32.78	+328.5%	USD/shares	10-K	2024-02-22
Annual	2022-12-31	8.98	-72.6%	USD/shares	10-K	2025-02-25
Annual	2023-12-31	9.95	+10.8%	USD/shares	10-K	2026-02-25
Annual	2024-12-31	-0.96	-109.6%	USD/shares	10-K	2026-02-25
Annual	2025-12-31	16.26	+1793.8%	USD/shares	10-K	2026-02-25

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2767000000.0	—	USD	10-Q	2016-05-10
Quarterly	2016-06-30	3281000000.0	+18.6%	USD	10-Q	2016-08-09
Quarterly	2016-09-30	3267000000.0	-0.4%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	3357000000.0	+2.8%	USD	10-Q	2017-11-06
Quarterly	2017-03-31	3975000000.0	+18.4%	USD	10-Q	2017-05-09
Quarterly	2017-06-30	4097000000.0	+3.1%	USD	10-Q	2017-08-07
Quarterly	2017-09-30	4493000000.0	+9.7%	USD	10-Q	2017-11-06
Quarterly	2017-12-31	4450000000.0	-1.0%	USD	10-Q	2018-11-02
Quarterly	2018-03-31	4507000000.0	+1.3%	USD	10-Q	2018-05-08
Quarterly	2018-06-30	4589000000.0	+1.8%	USD	10-Q	2018-08-06
Quarterly	2018-09-30	4498000000.0	-2.0%	USD	10-Q	2018-11-02
Quarterly	2018-12-31	4389000000.0	-2.4%	USD	10-Q	2019-11-01
Quarterly	2019-03-31	4518000000.0	+2.9%	USD	10-Q	2019-05-03
Quarterly	2019-06-30	4284000000.0	-5.2%	USD	10-Q	2019-08-01
Quarterly	2019-09-30	5381000000.0	+25.6%	USD	10-Q	2019-11-01
Quarterly	2019-12-31	5301000000.0	-1.5%	USD	10-Q	2020-10-29
Quarterly	2020-03-31	5177000000.0	-2.3%	USD	10-Q	2020-04-30
Quarterly	2020-06-30	5068000000.0	-2.1%	USD	10-Q	2020-07-30
Quarterly	2020-09-30	4641000000.0	-8.4%	USD	10-Q	2020-10-29
Quarterly	2020-12-31	4664000000.0	+0.5%	USD	10-Q	2021-10-28
Quarterly	2021-03-31	4632000000.0	-0.7%	USD	10-Q	2021-04-29
Quarterly	2021-06-30	3995000000.0	-13.8%	USD	10-Q	2021-08-04
Quarterly	2021-09-30	3993000000.0	-0.1%	USD	10-Q	2021-10-28
Quarterly	2021-12-31	3974000000.0	-0.5%	USD	10-Q	2022-10-27
Quarterly	2022-03-31	3975000000.0	+0.0%	USD	10-Q	2022-04-28
Quarterly	2022-06-30	4720000000.0	+18.7%	USD	10-Q	2022-07-28
Quarterly	2022-09-30	4470000000.0	-5.3%	USD	10-Q	2022-10-27
Quarterly	2022-12-31	4471000000.0	+0.0%	USD	10-Q	2023-10-26
Quarterly	2023-03-31	4472000000.0	+0.0%	USD	10-Q	2023-04-27
Quarterly	2023-06-30	4565000000.0	+2.1%	USD	10-Q	2023-07-27
Quarterly	2023-09-30	4565000000.0	+0.0%	USD	10-Q	2023-10-26
Quarterly	2023-12-31	4567000000.0	+0.0%	USD	10-Q	2024-10-31
Quarterly	2024-03-31	5307000000.0	+16.2%	USD	10-Q	2024-04-25
Quarterly	2024-06-30	5307000000.0	+0.0%	USD	10-Q	2024-07-25
Quarterly	2024-09-30	5308000000.0	+0.0%	USD	10-Q	2024-10-31
Quarterly	2024-12-31	5309000000.0	+0.0%	USD	10-Q	2025-10-30
Quarterly	2025-03-31	4761000000.0	-10.3%	USD	10-Q	2025-04-24
Quarterly	2025-06-30	4762000000.0	+0.0%	USD	10-Q	2025-08-01
Quarterly	2025-09-30	4763000000.0	+0.0%	USD	10-Q	2025-10-30
Annual	2016-12-31	3357000000.0	—	USD	10-K	2018-06-06
Annual	2017-12-31	4450000000.0	+32.6%	USD	10-K	2019-02-27
Annual	2018-12-31	4389000000.0	-1.4%	USD	10-K	2020-02-26
Annual	2019-12-31	5301000000.0	+20.8%	USD	10-K	2021-02-23
Annual	2020-12-31	4664000000.0	-12.0%	USD	10-K	2022-02-24
Annual	2021-12-31	3974000000.0	-14.8%	USD	10-K	2023-02-24
Annual	2022-12-31	4471000000.0	+12.5%	USD	10-K	2024-02-22
Annual	2023-12-31	4567000000.0	+2.1%	USD	10-K	2025-02-25
Annual	2024-12-31	5309000000.0	+16.2%	USD	10-K	2026-02-25
Annual	2025-12-31	9685000000.0	+82.4%	USD	10-K	2026-02-25

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	136000000.0	—	shares	10-Q	2017-05-09
Quarterly	2016-06-30	140000000.0	+2.9%	shares	10-Q	2017-08-07
Quarterly	2016-09-30	138000000.0	-1.4%	shares	10-Q	2017-11-06
Quarterly	2017-03-31	138000000.0	+0.0%	shares	10-Q	2018-05-08
Quarterly	2017-06-30	137000000.0	-0.7%	shares	10-Q	2018-08-06
Quarterly	2017-09-30	134000000.0	-2.2%	shares	10-Q	2018-11-02
Quarterly	2018-03-31	133000000.0	-0.7%	shares	10-Q	2019-05-03
Quarterly	2018-06-30	133000000.0	+0.0%	shares	10-Q	2019-08-01
Quarterly	2018-09-30	132000000.0	-0.8%	shares	10-Q	2019-11-01
Quarterly	2019-03-31	130000000.0	-1.5%	shares	10-Q	2020-04-30
Quarterly	2019-06-30	130000000.0	+0.0%	shares	10-Q	2020-07-30
Quarterly	2019-09-30	130000000.0	+0.0%	shares	10-Q	2020-10-29
Quarterly	2020-03-31	130000000.0	+0.0%	shares	10-Q	2021-04-29
Quarterly	2020-06-30	130000000.0	+0.0%	shares	10-Q	2021-08-04
Quarterly	2020-09-30	130000000.0	+0.0%	shares	10-Q	2021-10-28
Quarterly	2021-03-31	130000000.0	+0.0%	shares	10-Q	2022-04-28
Quarterly	2021-06-30	130000000.0	+0.0%	shares	10-Q	2022-07-28
Quarterly	2021-09-30	129000000.0	-0.8%	shares	10-Q	2022-10-27
Quarterly	2022-03-31	118000000.0	-8.5%	shares	10-Q	2023-04-27
Quarterly	2022-06-30	112000000.0	-5.1%	shares	10-Q	2023-07-27
Quarterly	2022-09-30	111000000.0	-0.9%	shares	10-Q	2023-10-26
Quarterly	2023-03-31	108000000.0	-2.7%	shares	10-Q	2024-04-25
Quarterly	2023-06-30	107000000.0	-0.9%	shares	10-Q	2024-07-25
Quarterly	2023-09-30	105000000.0	-1.9%	shares	10-Q	2024-10-31
Quarterly	2024-03-31	104000000.0	-1.0%	shares	10-Q	2025-04-24
Quarterly	2024-06-30	103000000.0	-1.0%	shares	10-Q	2025-08-01
Quarterly	2024-09-30	102000000.0	-1.0%	shares	10-Q	2025-10-30
Quarterly	2025-03-31	101000000.0	-1.0%	shares	10-Q	2025-04-24
Quarterly	2025-06-30	100000000.0	-1.0%	shares	10-Q	2025-08-01
Quarterly	2025-09-30	98000000.0	-2.0%	shares	10-Q	2025-10-30
Annual	2016-12-31	138000000.0	—	shares	10-K	2019-02-27
Annual	2017-12-31	136000000.0	-1.4%	shares	10-K	2020-02-26
Annual	2018-12-31	132000000.0	-2.9%	shares	10-K	2021-02-23
Annual	2019-12-31	130000000.0	-1.5%	shares	10-K	2022-02-24
Annual	2020-12-31	130000000.0	+0.0%	shares	10-K	2023-02-24
Annual	2021-12-31	129000000.0	-0.8%	shares	10-K	2024-02-22
Annual	2022-12-31	112000000.0	-13.2%	shares	10-K	2025-02-25
Annual	2023-12-31	106000000.0	-5.4%	shares	10-K	2026-02-25
Annual	2024-12-31	102000000.0	-3.8%	shares	10-K	2026-02-25
Annual	2025-12-31	99000000.0	-2.9%	shares	10-K	2026-02-25

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

9,685,000,000

Total Liabilities (latest annual)

21,478,000,000

Current Liabilities (latest annual)

14,004,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0217	—	ratio	10-Q	2017-05-09
Quarterly	2016-06-30	0.0068	-68.7%	ratio	10-Q	2017-08-07
Quarterly	2016-09-30	-0.0028	-141.9%	ratio	10-Q	2017-11-06
Quarterly	2017-03-31	0.0338	+1289.7%	ratio	10-Q	2018-11-02
Quarterly	2017-06-30	0.0039	-88.3%	ratio	10-Q	2018-11-02
Quarterly	2017-09-30	-0.0054	-236.4%	ratio	10-Q	2018-11-02
Quarterly	2018-03-31	0.0205	+479.9%	ratio	10-Q	2019-11-01
Quarterly	2018-06-30	0.0063	-69.3%	ratio	10-Q	2019-11-01
Quarterly	2018-09-30	0.0045	-27.9%	ratio	10-Q	2019-11-01
Quarterly	2019-03-31	0.0287	+533.8%	ratio	10-Q	2020-10-29
Quarterly	2019-06-30	0.0146	-49.1%	ratio	10-Q	2020-10-29
Quarterly	2019-09-30	0.0080	-45.2%	ratio	10-Q	2020-10-29
Quarterly	2020-03-31	0.0301	+276.6%	ratio	10-Q	2021-04-29
Quarterly	2020-06-30	0.0098	-67.6%	ratio	10-Q	2021-08-04
Quarterly	2020-09-30	0.0115	+17.8%	ratio	10-Q	2021-10-28
Quarterly	2021-03-31	0.0636	+453.6%	ratio	10-Q	2022-04-28
Quarterly	2021-06-30	0.0159	-75.0%	ratio	10-Q	2022-07-28
Quarterly	2021-09-30	0.0793	+399.7%	ratio	10-Q	2022-10-27
Quarterly	2022-03-31	0.0113	-85.8%	ratio	10-Q	2023-04-27
Quarterly	2022-06-30	0.0109	-3.0%	ratio	10-Q	2023-07-27
Quarterly	2022-09-30	0.0194	+77.0%	ratio	10-Q	2023-10-26
Quarterly	2023-03-31	0.0202	+4.5%	ratio	10-Q	2024-04-25
Quarterly	2023-06-30	0.0097	-52.0%	ratio	10-Q	2024-07-25
Quarterly	2023-09-30	0.0147	+50.8%	ratio	10-Q	2024-10-31
Quarterly	2024-03-31	0.0203	+38.4%	ratio	10-Q	2025-04-24
Quarterly	2024-06-30	0.0151	-25.6%	ratio	10-Q	2025-08-01
Quarterly	2024-09-30	-0.2209	-1564.4%	ratio	10-Q	2025-10-30
Quarterly	2025-03-31	0.0291	+113.2%	ratio	10-Q	2025-04-24
Quarterly	2025-06-30	0.0406	+39.5%	ratio	10-Q	2025-08-01
Quarterly	2025-09-30	0.0392	-3.5%	ratio	10-Q	2025-10-30
Annual	2016-12-31	0.0430	—	ratio	10-K	2019-02-27
Annual	2017-12-31	0.0578	+34.3%	ratio	10-K	2020-02-26
Annual	2018-12-31	0.0717	+24.1%	ratio	10-K	2021-02-23
Annual	2019-12-31	0.1035	+44.3%	ratio	10-K	2022-02-24
Annual	2020-12-31	0.0933	-9.8%	ratio	10-K	2023-02-24
Annual	2021-12-31	0.3183	+241.1%	ratio	10-K	2024-02-22
Annual	2022-12-31	0.1015	-68.1%	ratio	10-K	2025-02-25
Annual	2023-12-31	0.1109	+9.3%	ratio	10-K	2026-02-25
Annual	2024-12-31	-0.0110	-109.9%	ratio	10-K	2026-02-25
Annual	2025-12-31	0.2003	+1925.0%	ratio	10-K	2026-02-25

8-K Material Event Details

58 filings · 140 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

313 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-10	Qureshi Imran Ahmed	Global Head of Geographies	Equity grant / award A · derivative	Restricted Share Unit	125	$280.14	$35,101	3,072
2026-04-01	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	4,584	$290.70	$1,332,569	2,822
2026-03-03	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	27	$0.00	$0	2,588
2026-03-03	Furman Matthew	General Counsel	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	3,000	$304.00	$912,009	38,185
2026-02-26	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	2,104	$296.84	$624,551	139,243
2026-02-26	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award G	Ordinary Shares, nominal value $0.000304635 per share	68	$0.00	$0	11,988
2026-02-25	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	55,419	$0.00	$0	141,347
2026-02-13	Clarke Lucy	President of Risk & Broking	Open-market buy P	Ordinary Shares, nominal value $0.000304635 per share	3,500	$284.84	$996,929	19,250
2026-02-12	Hammond Michael P.	Dir	Open-market buy P	Ordinary Shares, nominal value $0.000304635 per share	241	$278.86	$67,205	2,505
2026-01-15	Qureshi Imran Ahmed	Global Head of Geographies	Equity grant / award A · derivative	Restricted Share Unit	5	$0.00	$0	1,649
2026-01-15	Qureshi Imran Ahmed	Global Head of Geographies	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	2,946
2026-01-15	Qureshi Imran Ahmed	Global Head of Geographies	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	5	$0.00	$0	2,220
2026-01-12	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	9	$329.45	$3,125	2,554
2026-01-12	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	155	$329.45	$50,990	3,354
2025-11-25	Qureshi Imran Ahmed	Global Head of Geographies	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	42	$317.52	$13,336	7,867
2025-11-05	Qureshi Imran Ahmed	Global Head of Geographies	Equity grant / award A · derivative	Restricted Share Unit	18	$0.00	$0	1,636
2025-10-15	Thomson-Hall Pamela	Head of International	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	4	$0.00	$0	5,840
2025-10-09	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	5	$337.39	$1,669	1,613
2025-10-09	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	41	$337.39	$13,851	2,889
2025-10-01	Clarke Lucy	President of Risk & Broking	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	315	$345.45	$108,817	15,688
2025-10-01	Clarke Lucy	President of Risk & Broking	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,577	$345.45	$544,775	16,003
2025-08-01	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A · derivative	Restricted Share Unit	57	$0.00	$0	8,121
2025-07-15	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	2	$0.00	$0	516
2025-07-15	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	3	$0.00	$0	1,097
2025-07-15	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	5	$0.00	$0	8,412
2025-07-11	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	41	$307.32	$12,556	1,094
2025-06-03	Krasner Andrew Jay	Chief Financial Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,600	$315.75	$505,200	11,982
2025-05-15	Beale Inga K	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	710	$0.00	$0	2,264
2025-05-15	Beale Inga K	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	412	$303.37	$124,988	1,554
2025-05-08	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	709	$310.74	$220,314	85,984
2025-05-08	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	2,891	$309.67	$895,256	86,693
2025-05-08	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	6,062	$308.78	$1,871,827	89,584
2025-05-08	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	192	$307.91	$59,118	95,646
2025-05-08	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	146	$306.85	$44,800	95,838
2025-04-21	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	64	$337.95	$21,629	95,984
2025-04-20	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	6,620	$0.00	$0	96,048
2025-04-15	Faber Alexis	Chief Operating Officer	Equity grant / award A · derivative	Restricted Share Unit	3	$0.00	$0	1,017
2025-04-15	Faber Alexis	Chief Operating Officer	Equity grant / award A · derivative	Restricted Share Unit	6	$0.00	$0	2,186
2025-04-15	Faber Alexis	Chief Operating Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	11	$0.00	$0	7,466
2025-04-10	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	0	$316.64	$5	513
2025-04-10	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	84	$316.64	$26,715	1,050
2025-04-01	Banas Kristy D	Chief Human Resources Officer	Exercise / conversion X · derivative	Dividend Equivalent Rights- 2022 RSU Award	9	$0.00	$0	0
2025-04-01	Banas Kristy D	Chief Human Resources Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,760	$337.95	$594,792	7,688
2025-04-01	Banas Kristy D	Chief Human Resources Officer	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	9	$0.00	$0	9,448
2025-03-03	Gebauer Julie Jarecke	Pres.-Health, Wealth & Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,616	$338.74	$547,405	72,793
2025-02-28	Gebauer Julie Jarecke	Pres.-Health, Wealth & Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	3,384	$335.77	$1,136,243	74,417
2025-02-27	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,349	$332.82	$448,974	111,613
2025-02-25	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	35,550	$0.00	$0	112,962
2025-02-10	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	19	$0.00	$0	663
2025-01-15	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU Award	2	$0.00	$0	22
2025-01-15	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	2	$0.00	$0	644
2025-01-15	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	4	$0.00	$0	1,564
2025-01-15	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	8	$0.00	$0	3,584
2025-01-10	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	9	$312.92	$2,916	1,565
2025-01-10	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	44	$312.92	$13,864	2,681
2024-11-18	Kurpis Joseph Stephen	PAO and Controller	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3	$312.65	$938	868
2024-11-07	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	4	$0.00	$0	488
2024-10-17	Thomson-Hall Pamela	Head of International	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3	$294.53	$884	3,742
2024-10-15	Thomson-Hall Pamela	Head of International	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU Award	0	$0.00	$0	6
2024-10-15	Thomson-Hall Pamela	Head of International	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	6	$0.00	$0	3,745
2024-10-15	Thomson-Hall Pamela	Head of International	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	4	$0.00	$0	3,739
2024-10-10	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	6	$290.24	$1,771	1,533
2024-10-10	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	48	$290.24	$13,865	2,629
2024-10-01	Clarke Lucy	President of Risk & Broking	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	5,156	$0.00	$0	18,462
2024-10-01	Clarke Lucy	President of Risk & Broking	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	9,980	$0.00	$0	13,306
2024-10-01	Clarke Lucy	President of Risk & Broking	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	3,326	$0.00	$0	3,326
2024-09-09	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion M · derivative	Dividend Equivalent Rights- 2021 RSU Award	192	$0.00	$0	0
2024-09-09	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,809	$291.09	$526,582	6,354
2024-09-09	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	192	$0.00	$0	8,163
2024-08-13	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	6	$0.00	$0	595
2024-07-22	Garrard Adam	Head of Risk & Broking	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,876	$263.13	$493,632	14,277
2024-07-15	Garrard Adam	Head of Risk & Broking	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU Award	1	$0.00	$0	15
2024-07-15	Garrard Adam	Head of Risk & Broking	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	22	$0.00	$0	16,153
2024-07-10	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	0	$258.16	$8	837
2024-07-10	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	58	$258.16	$15,052	2,079
2024-05-22	Tomczyk Fredric J	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	858	$0.00	$0	1,390
2024-05-17	Tomczyk Fredric J	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	423	$256.38	$108,449	532
2024-04-18	Pullum Anne	Head of Europe	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	2	$275.00	$550	15,594
2024-04-15	Qureshi Imran Ahmed	Head of North America	Exercise / conversion M · derivative	Dividend Equivalent Rights- 2022 RSU Award	1	$0.00	$0	11
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU Award	3	$0.00	$0	12
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	5	$0.00	$0	1,522
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	2,519
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	1	$0.00	$0	4,908
2024-04-15	Qureshi Imran Ahmed	Head of North America	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	1	$0.00	$0	4,907
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	3	$0.00	$0	4,906
2024-04-15	Qureshi Imran Ahmed	Head of North America	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	4	$0.00	$0	4,903
2024-04-11	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	91	$260.31	$23,715	823
2024-04-03	Qureshi Imran Ahmed	Head of North America	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	263	$275.00	$72,325	4,899
2024-04-03	Qureshi Imran Ahmed	Head of North America	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	128	$0.00	$0	5,162
2024-04-01	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X · derivative	Dividend Equivalent Rights- 2022 RSU Award	14	$0.00	$0	15
2024-04-01	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	228	$275.00	$62,700	7,955
2024-04-01	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	227	$275.00	$62,425	8,183
2024-04-01	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	14	$0.00	$0	9,109
2024-04-01	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	1,828	$0.00	$0	9,095
2024-03-01	Krasner Andrew Jay	Chief Financial Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,100	$272.13	$299,346	4,170
2024-02-28	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	159	$275.06	$43,735	74,757
2024-02-27	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	4,213	$0.00	$0	74,916
2024-02-20	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	5,000	$276.03	$1,380,144	68,574
2024-02-08	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	30	$0.00	$0	581
2024-01-16	Furman Matthew	General Counsel	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU Award	2	$0.00	$0	16
2024-01-16	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	2,373
2024-01-16	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	2,540
2024-01-16	Furman Matthew	General Counsel	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	3	$0.00	$0	30,815
2024-01-11	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Restricted Share Unit	33	$247.07	$8,258	275
2023-11-16	Kurpis Joseph Stephen	PAO and Controller	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	4	$241.44	$966	717
2023-11-09	Thomson-Hall Pamela	Head of International	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	330	$238.87	$78,828	3,324
2023-10-30	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	25	$0.00	$0	443
2023-10-16	Thomson-Hall Pamela	Head of International	Equity grant / award A · derivative	Dividend Equivalent Rights- 2021 RSU	8	$0.00	$0	62
2023-10-16	Thomson-Hall Pamela	Head of International	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU	1	$0.00	$0	7
2023-10-16	Thomson-Hall Pamela	Head of International	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	2	$0.00	$0	3,654
2023-10-09	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	11	$209.04	$2,398	417
2023-10-09	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	54	$209.04	$11,391	681
2023-09-07	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X · derivative	Dividend Equivalent Rights- 2021 RSU	128	$0.00	$0	129
2023-09-07	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,783	$204.54	$364,695	10,001
2023-09-07	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	128	$0.00	$0	11,784
2023-08-07	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	73	$0.00	$0	1,381
2023-07-20	Garrard Adam	Head of Risk & Broking	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,886	$226.72	$427,594	16,519
2023-07-17	Furman Matthew	General Counsel	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU	2	$0.00	$0	12
2023-07-17	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	2,248
2023-07-17	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	9	$0.00	$0	2,397
2023-07-17	Furman Matthew	General Counsel	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	17	$0.00	$0	31,849
2023-07-11	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	10	$235.08	$2,401	377
2023-07-11	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	49	$235.08	$11,407	625
2023-07-03	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	900	$230.14	$207,130	75,240
2023-07-03	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	600	$231.41	$138,844	76,140
2023-07-03	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	500	$234.82	$117,410	76,740
2023-06-07	Pullum Anne	Head of Europe	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	5,000	$224.45	$1,122,230	12,791
2023-06-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	2,500	$218.35	$545,868	77,240
2023-05-17	Tomczyk Fredric J	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	881	$0.00	$0	955
2023-05-17	Tomczyk Fredric J	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	69	$227.39	$15,690	74
2023-05-10	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Equity grant / award A · derivative	Restricted Share Unit	356	$0.00	$0	4,705
2023-05-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	2,500	$231.44	$578,590	79,740
2023-04-19	Kurpis Joseph Stephen	PAO and Controller	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1	$232.38	$232	720
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Dividend Equivalent Rights- 2021 RSU	32	$0.00	$0	224
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion M · derivative	Dividend Equivalent Rights- 2022 RSU	2	$0.00	$0	17
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Dividend Equivalent Rights- 2022 RSU	6	$0.00	$0	19
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	254
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	683
2023-04-17	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	2	$0.00	$0	11,647
2023-04-12	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Restricted Share Unit	0	$237.20	$15	197
2023-04-06	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	224	$232.38	$52,053	11,988
2023-04-01	Furman Matthew	General Counsel	Exercise / conversion X · derivative	Dividend Equivalent Rights	3	$0.00	$0	7
2023-04-01	Furman Matthew	General Counsel	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	3	$0.00	$0	31,994
2023-04-01	Furman Matthew	General Counsel	Equity grant / award A	Ordinary Shares, Nominal Value $0.000115 Per Share	952	$0.00	$0	971
2023-03-03	Furman Matthew	General Counsel	Exercise / conversion M · derivative	Stock Option (right to buy)	12,571	$0.00	$0	0
2023-03-03	Furman Matthew	General Counsel	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	9,080	$239.12	$2,171,210	31,991
2023-03-03	Furman Matthew	General Counsel	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	12,571	$116.68	$1,466,784	41,071
2023-03-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,404	$233.83	$328,300	82,550
2023-03-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,096	$232.86	$255,214	83,954
2023-02-14	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,360	$247.63	$336,783	85,050
2023-02-14	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	200	$246.38	$49,276	86,410
2023-02-14	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,440	$245.86	$354,044	86,610
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	350	$249.42	$87,296	9,164
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,181	$250.28	$295,577	9,514
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	200	$251.76	$50,353	10,695
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	800	$253.87	$203,098	10,895
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	700	$255.01	$178,507	11,695
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	470	$256.90	$120,744	12,395
2023-02-09	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,299	$257.23	$334,140	12,865
2023-02-06	Furman Matthew	General Counsel	Equity grant / award A · derivative	Restricted Share Unit	34	$0.00	$0	2,009
2023-02-06	Furman Matthew	General Counsel	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	3,611	$0.00	$0	28,500
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Dividend Equivalent Rights	29	$0.00	$0	212
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Dividend Equivalent Rights	6	$0.00	$0	183
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	140
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	140
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	289
2023-01-17	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	289
2023-01-10	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Equity grant / award A · derivative	Restricted Share Unit	23	$0.00	$0	21,737
2023-01-10	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Equity grant / award A · derivative	Restricted Share Unit	39	$253.38	$9,790	21,714
2022-11-21	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	5,000	$235.07	$1,175,374	83,355
2022-11-18	WICKES GENE H	Head of Benefits Deliv & Admin	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	8,112	$235.00	$1,906,320	61,563
2022-11-09	ONEILL BRENDAN R	Dir	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	6,520	$225.50	$1,470,246	7,488
2022-11-08	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	63	$0.00	$0	1,115
2022-11-03	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award G	Ordinary Shares, nominal value $0.000304635 per share	2,800	$0.00	$0	69,675
2022-11-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,400	$219.07	$306,704	88,355
2022-10-31	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	102	$218.77	$22,315	10,727
2022-10-31	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,898	$218.32	$414,374	10,829
2022-10-17	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Dividend Equivalent Rights	5	$0.00	$0	9
2022-10-17	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	637
2022-10-17	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	636
2022-10-17	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	2	$0.00	$0	1,387
2022-10-17	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	3	$0.00	$0	1,386
2022-10-07	Faber Alexis	Chief Operating Officer	Equity grant / award A · derivative	Restricted Share Unit	14	$204.93	$2,887	714
2022-10-07	Faber Alexis	Chief Operating Officer	Equity grant / award A · derivative	Restricted Share Unit	25	$0.00	$0	1,468
2022-10-07	Faber Alexis	Chief Operating Officer	Equity grant / award A · derivative	Restricted Share Unit	42	$204.93	$8,661	1,443
2022-10-04	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,400	$210.00	$294,000	89,755
2022-10-01	REILLY PAUL C	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	746	$0.00	$0	746
2022-09-07	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X · derivative	Dividend Equivalent Rights	64	$0.00	$0	135
2022-09-07	Krasner Andrew Jay	Chief Financial Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,030	$210.26	$216,570	2,178
2022-09-07	Krasner Andrew Jay	Chief Financial Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,758	$204.92	$360,249	13,200
2022-09-07	Krasner Andrew Jay	Chief Financial Officer	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	64	$0.00	$0	14,958
2022-09-02	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,400	$210.00	$294,003	91,155
2022-08-26	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M · derivative	Stock Option (right to buy)	10,000	$0.00	$0	13,925
2022-08-26	WICKES GENE H	Head of Benefits Deliv & Admin	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	10,000	$209.47	$2,094,700	72,475
2022-08-26	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	10,000	$110.58	$1,105,800	82,475
2022-08-18	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M · derivative	Stock Option (right to buy)	22,487	$0.00	$0	23,925
2022-08-18	WICKES GENE H	Head of Benefits Deliv & Admin	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	22,487	$220.00	$4,947,140	72,475
2022-08-18	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	22,487	$110.58	$2,486,612	94,962
2022-08-17	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M · derivative	Stock Option (right to buy)	398	$0.00	$0	46,412
2022-08-17	WICKES GENE H	Head of Benefits Deliv & Admin	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	398	$220.00	$87,560	72,475
2022-08-17	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	398	$110.58	$44,011	72,873
2022-08-16	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M · derivative	Stock Option (right to buy)	1,100	$0.00	$0	46,810
2022-08-16	WICKES GENE H	Head of Benefits Deliv & Admin	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,100	$220.02	$242,018	72,475
2022-08-16	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	1,100	$110.58	$121,638	73,575
2022-08-09	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	6,519	$0.00	$0	0
2022-08-09	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	5,129	$211.71	$1,085,861	61,048
2022-08-09	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	6,519	$110.58	$720,871	66,177
2022-08-08	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	6,519
2022-08-08	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,940	$210.67	$830,040	59,658
2022-08-08	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	63,598
2022-08-05	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	11,519
2022-08-05	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,950	$208.78	$824,681	58,598
2022-08-05	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	62,548
2022-08-04	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	16,519
2022-08-04	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,949	$208.92	$825,025	57,548
2022-08-04	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	61,497
2022-08-04	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Equity grant / award A · derivative	Restricted Share Unit	126	$0.00	$0	4,077
2022-08-03	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	21,519
2022-08-03	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,964	$206.33	$817,892	56,497
2022-08-03	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	60,461
2022-08-02	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	26,519
2022-08-02	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,978	$204.03	$811,631	55,461
2022-08-02	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	59,439
2022-08-01	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	5,000	$0.00	$0	31,519
2022-08-01	Hess Carl Aaron	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	3,973	$204.78	$813,591	54,439
2022-08-01	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	5,000	$110.58	$552,900	58,412
2022-07-20	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion X · derivative	Dividend Equivalent Rights	34	$0.00	$0	0
2022-07-20	WICKES GENE H	Head of Benefits Deliv & Admin	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,395	$198.47	$276,866	72,475
2022-07-20	WICKES GENE H	Head of Benefits Deliv & Admin	Exercise / conversion X	Ordinary Shares, nominal value $0.000304635 per share	34	$0.00	$0	73,870
2022-07-15	Garrard Adam	Head of Risk & Broking	Equity grant / award A · derivative	Dividend Equivalent Rights	5	$0.00	$0	5
2022-07-15	Garrard Adam	Head of Risk & Broking	Equity grant / award A · derivative	Dividend Equivalent Rights	14	$0.00	$0	25
2022-07-11	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award A · derivative	Restricted Share Unit	24	$0.00	$0	24,859
2022-07-11	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award A · derivative	Restricted Share Unit	41	$199.24	$8,220	24,835
2022-06-08	Beale Inga K	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	968	$0.00	$0	1,115
2022-06-08	Beale Inga K	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	136	$209.84	$28,538	147
2022-06-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,400	$210.67	$294,938	95,404
2022-05-26	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award G	Ordinary Shares, nominal value $0.000304635 per share	1,205	$0.00	$0	6,670
2022-05-11	ONEILL BRENDAN R	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	291	$206.35	$60,048	13,040
2022-05-11	Zeller Wilhelm	Dir	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	291	$206.35	$60,048	8,784
2022-05-06	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	16	$0.00	$0	218
2022-05-02	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	97	$215.98	$20,950	13,418
2022-05-02	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	300	$214.50	$64,350	13,515
2022-05-02	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	403	$213.62	$86,088	13,815
2022-05-02	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,200	$212.30	$254,755	14,218
2022-04-25	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	59	$0.00	$0	3,762
2022-04-25	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	101	$241.06	$24,289	3,703
2022-04-18	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	10	$0.00	$0	2,962
2022-04-18	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	5	$0.00	$0	3,603
2022-04-18	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	3,598
2022-04-18	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	3	$0.00	$0	852
2022-04-18	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	2	$0.00	$0	1,748
2022-04-18	Qureshi Imran Ahmed	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	4	$0.00	$0	1,746
2022-04-15	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Dividend Equivalent Rights	10	$0.00	$0	10
2022-04-01	Hess Carl Aaron	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	7,632	$0.00	$0	55,737
2022-03-01	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,400	$222.30	$311,220	98,407
2022-02-28	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	3,300	$0.00	$0	36,519
2022-02-28	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	3,300	$219.26	$723,558	44,805
2022-02-28	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	3,300	$110.58	$364,914	48,105
2022-02-25	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	3,300	$0.00	$0	39,819
2022-02-25	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	800	$220.85	$176,677	48,105
2022-02-25	Hess Carl Aaron	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	2,500	$220.97	$552,425	48,905
2022-02-25	Hess Carl Aaron	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	3,300	$110.58	$364,914	51,405
2022-02-22	Bodnar Anne Donovan	Chief Administrative Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	82	$225.61	$18,500	14,405
2022-02-22	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	2,958	$0.00	$0	14,487
2022-02-22	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,120	$223.76	$250,616	11,969
2022-02-22	Bodnar Anne Donovan	Chief Administrative Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	440	$225.06	$99,028	11,529
2022-02-14	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	2,400	$220.99	$530,375	95,396
2022-02-09	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	19	$0.00	$0	194
2022-01-18	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Dividend Equivalent Rights	1	$0.00	$0	1
2022-01-18	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	145
2022-01-18	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	126
2022-01-18	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A · derivative	Restricted Share Unit	0	$0.00	$0	126
2022-01-18	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award A · derivative	Restricted Share Unit	17	$0.00	$0	4,849
2022-01-18	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award A · derivative	Restricted Share Unit	8	$0.00	$0	24,474
2022-01-18	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award A · derivative	Restricted Share Unit	78	$0.00	$0	24,466
2022-01-10	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	9	$232.62	$2,008	174
2022-01-10	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	15	$0.00	$0	326
2022-01-10	Banas Kristy D	Chief Human Resources Officer	Equity grant / award A · derivative	Restricted Share Unit	26	$232.62	$6,025	311
2022-01-03	GANZI VICTOR F	Dir	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	265	$0.00	$0	22,297
2021-12-31	HALEY JOHN J	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,012	$237.49	$240,340	351,840
2021-12-31	HALEY JOHN J	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	2,570	$0.00	$0	352,852
2021-12-29	HALEY JOHN J	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	18,373	$238.72	$4,386,003	350,282
2021-12-29	HALEY JOHN J	Chief Executive Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	46,688	$0.00	$0	368,655
2021-12-03	HALEY JOHN J	Chief Executive Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	150,235	$0.00	$0	0
2021-12-03	HALEY JOHN J	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	1,014	$233.28	$236,546	0
2021-12-03	HALEY JOHN J	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	7,107	$232.29	$1,650,885	1,014
2021-12-03	HALEY JOHN J	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	12,879	$231.78	$2,985,095	8,121
2021-12-03	HALEY JOHN J	Chief Executive Officer	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	7,900	$230.55	$1,821,345	21,000
2021-12-03	HALEY JOHN J	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	63,808	$232.86	$14,858,331	321,967
2021-12-03	HALEY JOHN J	Chief Executive Officer	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	38,601	$232.84	$8,987,857	385,775
2021-12-03	HALEY JOHN J	Chief Executive Officer	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	150,235	$110.58	$16,612,986	424,376
2021-11-15	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Exercise / conversion M · derivative	Stock Option (right to buy)	42,010	$0.00	$0	0
2021-11-15	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Other disposed transaction D	Ordinary Shares, nominal value $0.000304635 per share	26,175	$229.28	$6,001,341	97,796
2021-11-15	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Other disposed transaction D	Ordinary Shares, nominal value $0.000304635 per share	15,835	$230.18	$3,644,938	123,971
2021-11-15	Gebauer Julie Jarecke	Head of Health, Wealth &Career	Exercise / conversion M	Ordinary Shares, nominal value $0.000304635 per share	42,010	$110.58	$4,645,466	139,806
2021-11-04	Bodnar Anne Donovan	Chief Administrative Officer	Equity grant / award A · derivative	Restricted Share Unit	110	$0.00	$0	2,830
2021-11-02	Garrard Adam	Head of Risk & Broking	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	110	$238.53	$26,238	9,557
2021-11-01	Garrard Adam	Head of Risk & Broking	Open-market sell S	Ordinary Shares, nominal value $0.000304635 per share	6,000	$236.36	$1,418,160	9,667
2021-10-15	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Dividend Equivalent Rights	3	$0.00	$0	41
2021-10-15	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	459
2021-10-15	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	459
2021-10-15	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	1	$0.00	$0	941
2021-10-15	Pullum Anne	Head of Europe	Equity grant / award A · derivative	Restricted Share Unit	2	$0.00	$0	940
2021-10-11	Hess Carl Aaron	President	Equity grant / award A · derivative	Restricted Share Unit	24	$0.00	$0	4,772
2021-10-11	Hess Carl Aaron	President	Equity grant / award A · derivative	Restricted Share Unit	40	$242.66	$9,788	4,749
2021-10-01	Kurpis Joseph Stephen	PAO and Controller	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	311	$0.00	$0	311
2021-09-07	Krasner Andrew Jay	Chief Financial Officer	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	13,210	$0.00	$0	13,709
2021-08-18	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award G	Ordinary Shares, nominal value $0.000304635 per share	1,300	$0.00	$0	5,465
2021-08-18	WICKES GENE H	Head of Benefits Deliv & Admin	Equity grant / award G	Ordinary Shares, nominal value $0.000304635 per share	821	$0.00	$0	70,903
2021-08-10	Bodnar Anne Donovan	CAO & Head of HR	Equity grant / award A · derivative	Restricted Share Unit	115	$0.00	$0	2,711
2021-07-20	Bodnar Anne Donovan	CAO & Head of HR	Other disposed transaction F	Ordinary Shares, nominal value $0.000304635 per share	1,581	$216.09	$341,638	13,530
2021-07-09	Gunn Joseph	Head of North America	Equity grant / award A · derivative	Restricted Share Unit	13	$228.21	$3,019	1,624
2021-06-15	Aubert Nicolas	Head of Great Britain	Equity grant / award A	Ordinary Shares, nominal value $0.000304635 per share	21	$0.00	$0	20,135

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count